- Home
- OBIO vs FCAP Comparison
OBIO vs FCAP Comparison
Compare OBIO & FCAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- FCAP
- Stock Information
- Founded
- OBIO 2017
- FCAP 1891
- Country
- OBIO United States
- FCAP United States
- Employees
- OBIO N/A
- FCAP N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- FCAP Savings Institutions
- Sector
- OBIO Health Care
- FCAP Finance
- Exchange
- OBIO Nasdaq
- FCAP Nasdaq
- Market Cap
- OBIO 118.8M
- FCAP 125.9M
- IPO Year
- OBIO N/A
- FCAP 1999
- Fundamental
- Price
- OBIO $2.57
- FCAP $37.00
- Analyst Decision
- OBIO Strong Buy
- FCAP
- Analyst Count
- OBIO 4
- FCAP 0
- Target Price
- OBIO $14.00
- FCAP N/A
- AVG Volume (30 Days)
- OBIO 403.6K
- FCAP 5.5K
- Earning Date
- OBIO 08-12-2025
- FCAP 07-25-2025
- Dividend Yield
- OBIO N/A
- FCAP 3.14%
- EPS Growth
- OBIO N/A
- FCAP 9.31
- EPS
- OBIO N/A
- FCAP 3.93
- Revenue
- OBIO $2,944,000.00
- FCAP $44,673,000.00
- Revenue This Year
- OBIO $20.47
- FCAP N/A
- Revenue Next Year
- OBIO $11.45
- FCAP N/A
- P/E Ratio
- OBIO N/A
- FCAP $9.41
- Revenue Growth
- OBIO 41.61
- FCAP 9.48
- 52 Week Low
- OBIO $2.37
- FCAP $28.50
- 52 Week High
- OBIO $7.04
- FCAP $53.85
- Technical
- Relative Strength Index (RSI)
- OBIO 40.46
- FCAP 43.83
- Support Level
- OBIO $2.50
- FCAP $37.01
- Resistance Level
- OBIO $2.75
- FCAP $38.29
- Average True Range (ATR)
- OBIO 0.18
- FCAP 1.17
- MACD
- OBIO -0.03
- FCAP 0.37
- Stochastic Oscillator
- OBIO 11.47
- FCAP 71.09
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About FCAP First Capital Inc.
First Capital Inc is the financial holding company of First Harrison Bank. Through its subsidiary, it operates as a federally-chartered savings bank that provides banking services to individuals and business customers across locations in America. The bank offers various loans which include residential loans, construction loans, commercial real estate loans and commercial business loans. It also provides consumer loans such as home equity and second mortgage loans, and automobile and truck loans.